BridgeMD
New treatment option for Gun Violence Prevention
Official title Supportive Hospital-Based Intervention for Firearm Trauma
ClinicalTrials.gov ID: NCT06712940
What this study is testing
- What it's testing
- This study is a quasi-experimental design, specifically a non-randomized controlled trial (NCT) designed to test the effects of gun violence reduction intervention including MI for youth ages 16-24 years old who present to the Emergency Department or ICU Spirit of Charity Trauma Center (SCTC) at University Medical Centers or another area hospital in New Orleans, Louisiana following a gunshot injury or stab wound. The study will utilize an enrollment strategy that involves alternating, across recruitment days, the assigned study condition.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 24
You may be able to join if
- 16 to 24 years old
- gunshot wound, stab wound, or assault related blunt force trauma injury treated at University Medical Center
- reside in the state of Louisiana
- capacity to provide voluntary informed consent or assent as approved by the Institutional Review Board of Tulane University
You likely can't join if
- not voluntarily agreeing to participate
- not available to participate in study activities in a private room
- age under 16 or over 24
- do not reside in the state of Louisiana
- not acknowledging English as their first language
- being in the judgment of the trauma surgery service as too physically compromised to participate
See the full eligibility criteria
- 16 to 24 years old
- gunshot wound, stab wound, or assault related blunt force trauma injury treated at University Medical Center
- reside in the state of Louisiana
- capacity to provide voluntary informed consent or assent as approved by the Institutional Review Board of Tulane University
- not voluntarily agreeing to participate
- not available to participate in study activities in a private room
- age under 16 or over 24
- do not reside in the state of Louisiana
- not acknowledging English as their first language
- being in the judgment of the trauma surgery service as too physically compromised to participate
- intellectual disability as estimated by clinician judgment following mental status examination
- current psychosis as evidenced by structured clinical interview and mental status examination that are administered on as needed basis
- current legal detention status
- injury was a result of intimate partner violence
- does not have the capacity to provide voluntary informed consent or assent as approved by the Institutional Review Board of Tulane University
The study team makes the final eligibility decision.
Where it's taking place
- New Orleans, Louisiana, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 24 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New Orleans, Louisiana, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.